TWiV 769: MIS-C and leaky gut
Jun 17, 2021•1 hr 46 min•Ep. 769
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
On this episode of TWiV, Novavax COVID-19 vaccine demonstrates 90% overall efficacy, preventing an antigenically disruptive change during growth of influenza virus vaccine in chicken eggs, and MIS-C is driven by loss of the gut mucosal barrier.
Hosts: Vincent Racaniello, Kathy Spindler, and Brianne Barker
Click arrow to play Download TWiV 769 (68 MB .mp3, 114 min) Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- ASV Vaccine Town Hall 2:05
- Novavax vaccine efficacy reported (Novavax)
- H3N2 glycosylation in eggs (TWiV 480)
- Preventing antigenically disruptive HA change in eggs (Cell Host Micr)
- MIS-C due to leaky gut (J Clin Invest)
- Letters read on TWiV 769
- Timestamps by Jolene. Thanks!
Brianne – Pandemics for Babies, Germ Theory for Babies, and Vaccines for Babies Kathy – Playing with Time Vincent – A Top Virologist in China, at Center of a Pandemic Storm, Speaks Out
Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv
For the best experience, listen in Metacast app for iOS or Android